Pfizer says its coronavirus vaccine is 95% effective and will seek U.S. approval within days

Advertisement

BEGIN ARTICLE PREVIEW:

Pfizer and BioNTech had initially estimated the vaccine was more than 90% effective after 94 infections had been counted in a study that included 44,000 people. With the new announcement, the company now has accumulated 170 infections in the study — and said only eight of them occurred in volunteers who got the actual vaccine rather than a dummy shot. One of those eight developed severe disease, the company said.

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE